Background Safe, effective vaccines against coronavirus disease 2019 (Covid-19) are urgently
needed in children younger than 12 years of age. Methods A phase 1, dose-finding study …

… Joining us for this edition are two new editors, Yvonne A. Maldonado and Victor Nizet. Bonnie
is an expert in pediatric HIV infection and is the Chief of the Division of Pediatric Infectious …

Guidance from the American Academy of Pediatrics (AAP) for the use of palivizumab
prophylaxis against respiratory syncytial virus (RSV) was first published in a policy statement in …

Background Safe and effective vaccines against coronavirus disease 2019 (Covid-19) are
urgently needed in young children. Methods We conducted a phase 1 dose-finding study and …

Since the first case of COVID-19 was identified in the USA in January, 2020, over 46 million
people in the country have tested positive for SARS-CoV-2 infection. Several COVID-19 …

The increasing diversity in the US population is reflected in the patients who healthcare
professionals treat. Unfortunately, this diversity is not always represented by the demographic …

This Clinical Report was revised. See https://doi.org/10.1542/peds.2023-065483 . Immunizations
have led to a significant decrease in rates of vaccine-preventable diseases and have …

Group B streptococcal (GBS) infection remains the most common cause of neonatal early-onset
sepsis and a signiicant cause of late-onset sepsis among young infants. Administration …

This Policy Statement was retired September 2016. Infections caused by Clostridium difficile
in hospitalized children are increasing. The recent publication of clinical practice guidelines …

This Clinical Report was retired July 2017. Most upper respiratory tract infections are caused
by viruses and require no antibiotics. This clinical report focuses on antibiotic prescribing …